Format
Sort by
Items per page

Send to

Choose Destination

Best matches for acute myocardial infarction AND intracoronary route AND mononuclear cells AND ventricular function, left:

Search results

Items: 20

1.

Efficacy of stem cell in improvement of left ventricular function in acute myocardial infarction--MI3 Trial.

Nair V, Madan H, Sofat S, Ganguli P, Jacob MJ, Datta R, Bharadwaj P, Sarkar RS, Pandit AJ, Nityanand S, Goel PK, Garg N, Gambhir S, George PV, Chandy S, Mathews V, George OK, Talwar KK, Bahl A, Marwah N, Bhatacharya A, Bhargava B, Airan B, Mohanty S, Patel CD, Sharma A, Bhatnagar S, Mondal A, Jose J, Srivastava A; MI3 Trial.

Indian J Med Res. 2015 Aug;142(2):165-74. doi: 10.4103/0971-5916.164245.

2.

Comparison of Different Bone Marrow-Derived Stem Cell Approaches in Reperfused STEMI. A Multicenter, Prospective, Randomized, Open-Labeled TECAM Trial.

San Roman JA, Sánchez PL, Villa A, Sanz-Ruiz R, Fernandez-Santos ME, Gimeno F, Ramos B, Arnold R, Serrador A, Gutiérrez H, Martin-Herrero F, Rollán MJ, Fernández-Vázquez F, López-Messa J, Ancillo P, Pérez-Ojeda G, Fernández-Avilés F.

J Am Coll Cardiol. 2015 Jun 9;65(22):2372-82. doi: 10.1016/j.jacc.2015.03.563.

3.

Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials.

de Jong R, Houtgraaf JH, Samiei S, Boersma E, Duckers HJ.

Circ Cardiovasc Interv. 2014 Apr;7(2):156-67. doi: 10.1161/CIRCINTERVENTIONS.113.001009. Epub 2014 Mar 25. Erratum in: Circ Cardiovasc Interv. 2014 Jun;7(3):424.

4.

Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.

Assmus B, Leistner DM, Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Sedding D, Yu J, Corti R, Mathey DG, Barth C, Mayer-Wehrstein C, Burck I, Sueselbeck T, Dill T, Hamm CW, Tonn T, Dimmeler S, Zeiher AM; REPAIR-AMI Study Group.

Eur Heart J. 2014 May 14;35(19):1275-83. doi: 10.1093/eurheartj/ehu062. Epub 2014 Feb 25.

PMID:
24569031
5.

Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.

Sürder D, Manka R, Lo Cicero V, Moccetti T, Rufibach K, Soncin S, Turchetto L, Radrizzani M, Astori G, Schwitter J, Erne P, Zuber M, Auf der Maur C, Jamshidi P, Gaemperli O, Windecker S, Moschovitis A, Wahl A, Bühler I, Wyss C, Kozerke S, Landmesser U, Lüscher TF, Corti R.

Circulation. 2013 May 14;127(19):1968-79. doi: 10.1161/CIRCULATIONAHA.112.001035. Epub 2013 Apr 17.

6.

The effects of intracoronary delivery of mononuclear bone marrow cells in patients with myocardial infarction: a two year follow-up results.

Plewka M, Krzemińska-Pakuła M, Peruga JZ, Lipiec P, Kurpesa M, Wierzbowska-Drabik K, Korycka-Wołowiec A, Kasprzak JD.

Kardiol Pol. 2011;69(12):1234-40.

7.

Regional myocardial function after intracoronary bone marrow cell injection in reperfused anterior wall infarction - a cardiovascular magnetic resonance tagging study.

Hopp E, Lunde K, Solheim S, Aakhus S, Arnesen H, Forfang K, Edvardsen T, Smith HJ.

J Cardiovasc Magn Reson. 2011 Mar 17;13:22. doi: 10.1186/1532-429X-13-22.

8.

Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction.

Plewka M, Krzemińska-Pakuła M, Lipiec P, Peruga JZ, Jezewski T, Kidawa M, Wierzbowska-Drabik K, Korycka A, Robak T, Kasprzak JD.

Am J Cardiol. 2009 Nov 15;104(10):1336-42. doi: 10.1016/j.amjcard.2009.06.057. Epub 2009 Sep 25.

PMID:
19892047
9.

Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trial.

Schächinger V, Assmus B, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Yu J, Corti R, Mathey DG, Hamm CW, Tonn T, Dimmeler S, Zeiher AM; REPAIR-AMI investigators.

Eur J Heart Fail. 2009 Oct;11(10):973-9. doi: 10.1093/eurjhf/hfp113.

10.

Intracoronary administration of stem cells in patients with acute myocardial infarction - angiographic follow-up.

Peruga J, Plewka M, Kasprzak J, Jezewski T, Wierzbicka A, Robak T, Krzemińska-Pakuła M.

Kardiol Pol. 2009 May;67(5):477-84.

11.

Inflammatory responses after intracoronary mononuclear BM cell therapy in swine.

Xu S, Xu X, Guo Y, Gao W.

Bone Marrow Transplant. 2009 Oct;44(7):427-31. doi: 10.1038/bmt.2009.52. Epub 2009 Mar 30.

PMID:
19333231
12.

Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.

Huikuri HV, Kervinen K, Niemelä M, Ylitalo K, Säily M, Koistinen P, Savolainen ER, Ukkonen H, Pietilä M, Airaksinen JK, Knuuti J, Mäkikallio TH; FINCELL Investigators.

Eur Heart J. 2008 Nov;29(22):2723-32. doi: 10.1093/eurheartj/ehn436. Epub 2008 Oct 9.

PMID:
18845667
13.

Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial.

Hirsch A, Nijveldt R, van der Vleuten PA, Tio RA, van der Giessen WJ, Marques KM, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Biemond BJ, Tijssen JG, van Rossum AC, Piek JJ, Zijlstra F.

Catheter Cardiovasc Interv. 2008 Feb 15;71(3):273-81. doi: 10.1002/ccd.21337.

PMID:
18288734
14.
15.

[Autologous mononuclear bone marrow cell transplantation by intracoronary route for patients with ischemic heart disease: observation of 2-years follow-up].

Gao LR, Wang ZG, Tian HT, Zhu ZM, Fei YX, Xu HT, Chen Y, Zhu JR, He S, Zhang NK, Ding QA, Yang Y.

Zhonghua Yi Xue Za Zhi. 2007 Mar 13;87(10):685-9. Chinese.

PMID:
17553306
16.

Intracoronary delivery of autologous bone marrow mononuclear cells radiolabeled by 18F-fluoro-deoxy-glucose: tissue distribution and impact on post-infarct swine hearts.

Qian H, Yang Y, Huang J, Gao R, Dou K, Yang G, Li J, Shen R, He Z, Lu M, Zhao S.

J Cell Biochem. 2007 Sep 1;102(1):64-74.

PMID:
17407141
17.

[Cardiomyoplasty with autological mononuclear cells of the bone marrow in patients with acute myocardial infarction].

Riabov VV, Suslova TE, Krylov AL, Poponina IuS, Vesnina ZhV, Sazonova SI, Markov VA, Popov SV, Karpov RS.

Ter Arkh. 2006;78(8):47-52. Russian.

PMID:
17078217
18.

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.

Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grøgaard HK, Bjørnerheim R, Brekke M, Müller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K.

N Engl J Med. 2006 Sep 21;355(12):1199-209.

19.

Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.

Hirsch A, Nijveldt R, van der Vleuten PA, Biemond BJ, Doevendans PA, van Rossum AC, Tijssen JG, Zijlstra F, Piek JJ; HEBE investigators.

Am Heart J. 2006 Sep;152(3):434-41.

PMID:
16923409
20.

Autologous bone marrow-derived progenitor cell transplantation for myocardial regeneration after acute infarction.

Obradović S, Rusović S, Balint B, Ristić-Andelkov A, Romanović R, Baskot B, Vojvodić D, Gligić B.

Vojnosanit Pregl. 2004 Sep-Oct;61(5):519-29.

PMID:
15551805

Supplemental Content

Loading ...
Support Center